Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology.
Lorenz J, Rothhammer-Hampl T, Zoubaa S, Bumes E, Pukrop T, Kölbl O, Corbacioglu S, Schmidt NO, Proescholdt M, Hau P, Riemenschneider MJ. Lorenz J, et al. Among authors: rothhammer hampl t. Acta Neuropathol Commun. 2020 Aug 5;8(1):124. doi: 10.1186/s40478-020-01000-w. Acta Neuropathol Commun. 2020. PMID: 32758285 Free PMC article.
TGF-ß isoforms in cancer: Immunohistochemical expression and Smad-pathway-activity-analysis in thirteen major tumor types with a critical appraisal of antibody specificity and immunohistochemistry assay validity.
Riemenschneider MJ, Hirblinger M, Vollmann-Zwerenz A, Hau P, Proescholdt MA, Jaschinski F, Rothhammer-Hampl T, Wosikowski K, Janicot M, Leo E. Riemenschneider MJ, et al. Among authors: rothhammer hampl t. Oncotarget. 2015 Sep 29;6(29):26770-81. doi: 10.18632/oncotarget.5780. Oncotarget. 2015. PMID: 26450853 Free PMC article.
Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019.
Riemenschneider MJ, Fischer J, Grassow-Narlik M, Mawrin C, von Deimling A, Pietsch T, Reifenberger G, Mueller WC, Sommer CJ, Dietel M, Zoubaa S, Lorenz J, Rothhammer-Hampl T. Riemenschneider MJ, et al. Among authors: rothhammer hampl t. Clin Neuropathol. 2020 Sep/Oct;39(5):203-211. doi: 10.5414/NP301278. Clin Neuropathol. 2020. PMID: 32352373
Induced neural progenitor cells and iPS-neurons from major depressive disorder patients show altered bioenergetics and electrophysiological properties.
Triebelhorn J, Cardon I, Kuffner K, Bader S, Jahner T, Meindl K, Rothhammer-Hampl T, Riemenschneider MJ, Drexler K, Berneburg M, Nothdurfter C, Manook A, Brochhausen C, Baghai TC, Hilbert S, Rupprecht R, Milenkovic VM, Wetzel CH. Triebelhorn J, et al. Among authors: rothhammer hampl t. Mol Psychiatry. 2022 Jun 22. doi: 10.1038/s41380-022-01660-1. Online ahead of print. Mol Psychiatry. 2022. PMID: 35732695
Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin.
Seliger C, Meyer AL, Leidgens V, Rauer L, Moeckel S, Jachnik B, Proske J, Dettmer K, Rothhammer-Hampl T, Kaulen LD, Riemenschneider MJ, Oefner PJ, Kreutz M, Schmidt NO, Merrill M, Uhl M, Renner K, Vollmann-Zwerenz A, Proescholdt M, Hau P. Seliger C, et al. Among authors: rothhammer hampl t. Int J Mol Sci. 2022 Oct 1;23(19):11629. doi: 10.3390/ijms231911629. Int J Mol Sci. 2022. PMID: 36232951 Free PMC article.
Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021.
Pohl S, Dimitrova L, Grassow-Narlik M, Jöhrens K, Acker T, Dohmen H, Herms J, Dorostkar M, Hartmann C, Hasselblatt M, Neumann M, Reifenberger G, Felsberg J, Schüller U, Zoubaa S, Lorenz J, Rothhammer-Hampl T, Mauch-Mücke K, Riemenschneider MJ. Pohl S, et al. Among authors: rothhammer hampl t. Clin Neuropathol. 2023 May-Jun;42(3):112-121. doi: 10.5414/NP301547. Clin Neuropathol. 2023. PMID: 36999511
Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype.
Braun FK, Rothhammer-Hampl T, Lorenz J, Pohl S, Menevse AN, Vollmann-Zwerenz A, Bumes E, Büttner M, Zoubaa S, Proescholdt M, Schmidt NO, Hau P, Beckhove P, Winner B, Riemenschneider MJ. Braun FK, et al. Among authors: rothhammer hampl t. Cells. 2023 Jul 14;12(14):1856. doi: 10.3390/cells12141856. Cells. 2023. PMID: 37508520 Free PMC article.
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages.
Weidner L, Lorenz J, Quach S, Braun FK, Rothhammer-Hampl T, Ammer LM, Vollmann-Zwerenz A, Bartos LM, Dekorsy FJ, Holzgreve A, Kirchleitner SV, Thon N, Greve T, Ruf V, Herms J, Bader S, Milenkovic VM, von Baumgarten L, Menevse AN, Hussein A, Sax J, Wetzel CH, Rupprecht R, Proescholdt M, Schmidt NO, Beckhove P, Hau P, Tonn JC, Bartenstein P, Brendel M, Albert NL, Riemenschneider MJ. Weidner L, et al. Among authors: rothhammer hampl t. Acta Neuropathol Commun. 2023 Sep 11;11(1):147. doi: 10.1186/s40478-023-01651-5. Acta Neuropathol Commun. 2023. PMID: 37697350 Free PMC article.
11 results